Advanced search
Publication Cover
Clinical Ophthalmology Volume 17, 2023 - Issue
Submit an article Journal homepage
242
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Limited Clinical Value of Anti-Retinal Antibody Titers and Numbers in Autoimmune Retinopathy

Ploysai Rujkorakarn1 Massachusetts Eye Research and Surgery Institution, Waltham, MA, USA;2 The Ocular Immunology and Uveitis Foundation, Waltham, MA, USA;3 Suddhavej Hospital Department of Ophthalmology, Mahasarakham University, Maha Sarakham, ThailandORCID Iconhttps://orcid.org/0000-0003-4718-8744
ORCID Icon,
Michael J Margolis1 Massachusetts Eye Research and Surgery Institution, Waltham, MA, USA;2 The Ocular Immunology and Uveitis Foundation, Waltham, MA, USA
,
Diana Morvey1 Massachusetts Eye Research and Surgery Institution, Waltham, MA, USA;2 The Ocular Immunology and Uveitis Foundation, Waltham, MA, USA
,
Yujia Zhou1 Massachusetts Eye Research and Surgery Institution, Waltham, MA, USA;2 The Ocular Immunology and Uveitis Foundation, Waltham, MA, USAORCID Iconhttps://orcid.org/0000-0002-7779-1897
ORCID Icon &
C Stephen Foster1 Massachusetts Eye Research and Surgery Institution, Waltham, MA, USA;2 The Ocular Immunology and Uveitis Foundation, Waltham, MA, USA;4 Department of Ophthalmology, Harvard Medical School, Cambridge, MA, USACorrespondence[email protected]
Pages 749-755 | Received 14 Jan 2023, Accepted 01 Mar 2023, Published online: 07 Mar 2023

References

  • Braithwaite T, Vugler A, Tufail A. Autoimmune retinopathy. Ophthalmologica. 2012;228(3):131–142. doi:10.1159/000338240
  • Ten Berge JC, Schreurs MW, Vermeer J, Meester-Smoor MA, Rothova A. Prevalence and clinical impact of antiretinal antibodies in uveitis. Acta Ophthalmol. 2016;94(3):282–288. doi:10.1111/aos.12939
  • Marmor MF, Fulton AB, Holder GE, et al. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol. 2009;118(1):69–77. doi:10.1007/s10633-008-9155-4
  • McCulloch DL, Marmor MF, Brigell MG, et al. ISCEV Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol. 2015;130(1):1–12. doi:10.1007/s10633-014-9473-7
  • Zacks DN, Samson CM, Loewenstein J, Foster CS. Electroretinograms as an indicator of disease activity in birdshot retinochoroidopathy. Graefes Arch Clin Exp Ophthalmol. 2002;240(8):601–607. doi:10.1007/s00417-002-0506-7
  • Maleki A, Ueberroth JA, Manhapra A, et al. Fixed-luminance and multi-luminance flicker electroretinography parameters in patients with early active birdshot chorioretinopathy. Ocul Immunol Inflamm. 2022;30(1):129–135. doi:10.1080/09273948.2020.1797113
  • Silpa-Archa S, Lee JJ, Boonsopon S, et al. Poor prognostic factors in patients with birdshot retinochoroidopathy. Retina. 2016;36(11):2220–2226. doi:10.1097/IAE.0000000000001051
  • Maleki A, Swan RT, Silpa-Archa S, Preble JM, He Y, Foster CS. Short-wavelength automated perimetry parameters at baseline and following remission in patients with birdshot retinochoroidopathy. Am J Ophthalmol. 2016;163(83–92.e6). doi:10.1016/j.ajo.2015.11.024
  • Forooghian F, Macdonald IM, Heckenlively JR, et al. The need for standardization of antiretinal antibody detection and measurement. Am J Ophthalmol. 2008;146(4):489–495. doi:10.1016/j.ajo.2008.05.046
  • Fox AR, Sen HN, Nussenblatt RB. Chapter 80. Autoimmune Retinopathies. In: Schachat AP, Wilkinson CP, Hinton DR, Sadda SR, Wiedemann P, editors. Ryan: Retina. 6th ed. Elsevier Inc; 2018:1562–1572.
  • Grange L, Dalal M, Nussenblatt RB, Sen HN. Autoimmune retinopathy. Am J Ophthalmol. 2014;157(2):266–272.e1. doi:10.1016/j.ajo.2013.09.019
  • Bagheri S, Sobrin L. Autoimmune retinopathy: challenges in diagnosis and management. Adv Ophthalmol Optom. 2018;3(1):375–387. doi:10.1016/j.yaoo.2018.04.018
  • Chen JJ, McKeon A, Greenwood TM, et al. Clinical utility of antiretinal antibody testing. JAMA Ophthalmol. 2021;139(6):658–662. doi:10.1001/jamaophthalmol.2021.0651
  • Comlekoglu DU, Thompson IA, Sen HN. Autoimmune retinopathy. Curr Opin Ophthalmol. 2013;24(6):598–605. doi:10.1097/ICU.0b013e3283654e1e
  • Heckenlively JR, Lundy SK. Autoimmune retinopathy: an immunologic cellular-driven disorder. Adv Exp Med Biol. 2018;1074:193–201. doi:10.1007/978-3-319-75402-4_24
  • Fox AR, Gordon LK, Heckenlively JR, et al. Consensus on the diagnosis and management of nonparaneoplastic autoimmune retinopathy using a modified delphi approach. Am J Ophthalmol. 2016;168:183–190. doi:10.1016/j.ajo.2016.05.013
  • Saito W, Kase S, Ohguro H, Ishida S. Autoimmune retinopathy associated with colonic adenoma. Graefes Arch Clin Exp Ophthalmol. 2013;251(5):1447–1449. doi:10.1007/s00417-012-2131-4
  • Adamus G, Champaigne R, Yang S. Occurrence of major anti-retinal autoantibodies associated with paraneoplastic autoimmune retinopathy. Clin Immunol. 2020;210:108317. PMID: 31770612; PMCID: PMC6989367. doi:10.1016/j.clim.2019.108317
  • Adamus G. Latest updates on antiretinal autoantibodies associated with vision loss and breast cancer. Invest Ophthalmol Vis Sci. 2015;56(3):1680–1688. doi:10.1167/iovs.14-15739
  • Keltner JL, Thirkill CE, Tyler NK, Roth AM. Management and monitoring of cancer-associated retinopathy. Arch Ophthalmol. 1992;110(1):48–53. doi:10.1001/archopht.1992.01080130050025
  • Eltabbakh GH, Hoogerland DL, Kay MC. Paraneoplastic retinopathy associated with uterine sarcoma. Gynecol Oncol. 1995;58(1):120–123. doi:10.1006/gyno.1995.1194
  • Murphy MA, Thirkill CE, Hart WM Jr. Paraneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinoma. J Neuroophthalmol. 1997;17(2):77–83.
  • Guy J, Aptsiauri N. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases. Arch Ophthalmol. 1999;117(4):471–477. doi:10.1001/archopht.117.4.471
  • Stanwyck LK, Moussa K, Chan W, Aitken PA, Sobrin L. Lack of correlation between number of antiretinal antibodies and clinical outcome measures in autoimmune retinopathy patients. Ophthalmol Retina. 2019;3(11):1007–1009. doi:10.1016/j.oret.2019.06.007
  • Moussa K, Stanwyck LK, Sobrin L. Correlation of anti-retinal antibodies with clinical outcome measures before and after immunosuppressive treatment in autoimmune retinopathy patients. Invest Ophthalmol Vis Sci. 2018;59(9):4209.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.